Canine Renin Recombinant

• Description:

  Canine Renin Recombinant_x000D_ Catalog number: B2017081_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -80C_x000D_ Keywords: Canine Renin Recombinant_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Pilote L, McKercher G, Thibeault D, Lamarre D. Enzymatic characterization of purified recombinant human renin Biochem Cell Biol. 1995 Mar-Apr;73(3-4):163-70._x000D_ 2: Evans DB, Cornette JC, Sawyer TK, Staples DJ, de Vaux AE, Sharma SK. Substrate specificity and inhibitor structure-activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors Biotechnol Appl Biochem. 1990 Apr;12(2):161-75._x000D_ 3: Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G. Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer PLoS One. 2022 Jul 11;17(7):e0271066._x000D_ 4: Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G. Development of a novel, pan-variant aerosol intervention for COVID-19 bioRxiv [Preprint]. 2021 Sep 20:2021.09.14.459961._x000D_ 5: Shibasaki M, Shibasaki K, Ichihara M, Inagaki O, Yanagisawa I, Takenaka T, Murakami K. Pharmacological properties of YM-26365, a low molecular weight, orally active renin inhibitor Eur J Pharmacol. 1994 Dec 27;271(2-3):341-8._x000D_ 6: Nakagawa T, Akaki J, Satou R, Takaya M, Iwata H, Katsurada A, Nishiuchi K, Ohmura Y, Suzuki F, Nakamura Y. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin Biol Chem. 2007 Feb;388(2):237-46._x000D_ 7: Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A, Redfield MM, Potter LR, Burnett JC Jr, Simari RD. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11282-7._x000D_ 8: Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PM, Milligan G. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells Kidney Int. 2009 Dec;76(12):1258-67._x000D_ 9: Weighous TF, Cornette JC, Sharma SK, Tarpley WG. Secretion of enzymatically active human renin from mammalian cells using an avian retroviral vector Gene. 1986;45(2):121-9._x000D_ 10: Larouche-Lebel É, Loughran KA, Oyama MA, Solter PF, Laughlin DS, Sánchez MD, Assenmacher CA, Fox PR, Fries RC. Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease J Vet Intern Med. 2019 Jul;33(4):1571-1584. _x000D_ _x000D_ Products Related to Canine Renin Recombinant can be found at Proteins

• Short Description:

  Catalog Number: B2017081 (50 ug)_x000D_ Canine Renin Recombinant is a high quality Canine Renin Recombinant. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3